Wei; Guo Ping

Patent Applications and Registrations

Patent applications and USPTO patent grants for Wei; Guo Ping.The latest application filed is for "diamine derivatives as inhibitors of leukotriene a4 hydrolase".

Company Profile

1.20.23

Wei; Guo Ping - San Ramon CA
Wei; Guo Ping - Richmond CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Diamine derivatives as inhibitors of leukotriene A4 hydrolase Grant 11,267,819 - Arnaiz , et al. March 8, 2	2022-03-08
Diamine Derivatives As Inhibitors Of Leukotriene A4 Hydrolase App 20200308181 - Arnaiz; Damian O. ; et al.	2020-10-01
Diamine Derivatives As Inhibitors Of Leukotriene A4 Hydrolase App 20180230159 - Arnaiz; Damian O. ; et al.	2018-08-16
Diamine Derivatives As Inhibitors Of Leukotriene A4 Hydrolase App 20160272649 - Arnaiz; Damian O. ; et al.	2016-09-22
Diamine derivatives as inhibitors of leukotriene A4 hydrolase Grant 9,315,509 - Arnaiz , et al. April 19, 2	2016-04-19
Diamine Derivatives As Inhibitors Of Leukotriene A4 Hydrolase App 20150080382 - Arnaiz; Damian O. ; et al.	2015-03-19
Diamine derivatives as inhibitors of leukotriene A4 hydrolase Grant 8,569,303 - Arnaiz , et al. October 29, 2	2013-10-29
Diamine Derivatives As Inhibitors Of Leukotriene A4 Hydrolase App 20130123243 - Arnaiz; Damian O. ; et al.	2013-05-16
Diamine Derivatives as Inhibitors of Leukotriene A4 Hydrolase App 20100210630 - Arnaiz; Damian ; et al.	2010-08-19
Diamine derivatives as inhibitors of leukotriene A.sub.4 hydrolase Grant 7,737,145 - Arnaiz , et al. June 15, 2	2010-06-15
Piperazine derivatives and their use as anti-inflammatory agents Grant 7,268,140 - Bauman , et al. September 11, 2	2007-09-11
Amide inhibitors of leukotriene A4 hydrolase App 20070155727 - Chen; Ming ; et al.	2007-07-05
Diamine derivatives as inhibitors of leukotriene A4 hydrolase App 20070155726 - Arnaiz; Damian ; et al.	2007-07-05
Substituted quinoline CCR5 receptor antagonists Grant 7,220,856 - Dunning , et al. May 22, 2	2007-05-22
N-heterocyclic derivatives as NOS inhibitors Grant 7,202,263 - Davey , et al. April 10, 2	2007-04-10
Platelet adenosine diphosphate receptor antagonists Grant 7,084,142 - Bryant , et al. August 1, 2	2006-08-01
Piperidine derivatives and their use as anti-inflammatory agents App 20060167044 - Arnaiz; Damian O. ; et al.	2006-07-27
Piperazine derivatives and their use as anti-inflammatory agents App 20060135487 - Bauman; John G. ; et al.	2006-06-22
Platelet adenosine diphosphate receptor antagonists App 20060135532 - Bryant; Judi A. ; et al.	2006-06-22
Platelet adenosine diphosphate receptor antagonists App 20060122188 - Bryant; Judi ; et al.	2006-06-08
Platelet adenosine diphosphate receptor antagonists Grant 7,056,923 - Bryant , et al. June 6, 2	2006-06-06
N-heterocyclic derivatives as NOS inhibitors App 20060094725 - Davey; David D. ; et al.	2006-05-04
Platelet adenosine diphosphate receptor antagonists Grant 7,026,323 - Bryant , et al. April 11, 2	2006-04-11
Platelet adenosine diphosphate receptor antagonists Grant 6,995,156 - Bryant , et al. February 7, 2	2006-02-07
N-heterocyclic derivatives as NOS inhibitors Grant 6,982,259 - Davey , et al. January 3, 2	2006-01-03
Piperazine derivatives and their use as anti-inflammatory agents Grant 6,977,258 - Bauman , et al. December 20, 2	2005-12-20
Piperazine derivatives and their use as anti-inflammatory agents Grant 6,972,290 - Bauman , et al. December 6, 2	2005-12-06
Benzylether amine compounds useful as CCR-5 antagonists App 20050101644 - Davey, David ; et al.	2005-05-12
Platelet adenosine diphosphate receptor antagonists App 20050065163 - Bryant, Judi A. ; et al.	2005-03-24
Platelet adenosine diphosphate receptor antagonists Grant 6,861,424 - Bryant , et al. March 1, 2	2005-03-01
Platelet adenosine diphosphate receptor antagonists App 20050038037 - Bryant, Judi A. ; et al.	2005-02-17
Platelet adenosine diphosphate receptor antagonists App 20040138229 - Bryant, Judi ; et al.	2004-07-15
Substituted quinoline CCR5 receptor antagonists App 20040072818 - Dunning, Laura ; et al.	2004-04-15
N-heterocyclic derivatives as NOS inhibitors App 20040023950 - Davey, David D. ; et al.	2004-02-05
Piperazine derivatives and their use as anti-inflammatory agents App 20030158205 - Bauman, John G. ; et al.	2003-08-21
Piperazine derivatives and their use as anti-inflammatory agents App 20030139425 - Bauman, John G. ; et al.	2003-07-24
Piperazine derivatives and their use as anti-inflammatory agents Grant 6,555,537 - Bauman , et al. April 29, 2	2003-04-29
Piperazine derivatives and their use as anti-inflammatory agents Grant 6,541,476 - Bauman , et al. April 1, 2	2003-04-01
Platelet adenosine diphosphate receptor antagonists App 20030060474 - Bryant, Judi A. ; et al.	2003-03-27
Piperazine derivatives and their use as anti-inflammatory agents Grant 6,534,509 - Bauman , et al. March 18, 2	2003-03-18
Piperazine derivatives and their use as anti-inflammatory agents App 20020177598 - Bauman, John G. ; et al.	2002-11-28
Piperazine derivatives and their use as anti-inflammatory agents Grant 6,207,665 - Bauman , et al. March 27, 2	2001-03-27

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.